Mike Poole, MD, FACP

With more than 25 years of experience in the pharmaceutical industry, Dr. Mike Poole has held leadership positions at the Bill and Melinda Gates Foundation, Pfizer, AstraZeneca, and others.

Dr. Mike Poole biomatics capital mms holdings bill and melinda gates foundation astrazeneca pfizer wyeth link medicine hypinion cro services vendor consultant clinical development plans cdp nda inda fda filingMike identifies and evaluates potential investments for Biomatics Capital, a small venture capital firm in Seattle. He supports portfolio companies with transitional and operational leadership, leveraging his deep experience working with large pharma and venture-funded biotechnology companies.

Most recently, Dr. Poole led external investments in the Office of the President for Global Health at the Bill and Melinda Gates Foundation. Prior to joining the Gates Foundation, Dr. Poole served as Vice President and head of Neuroscience Innovation at AstraZeneca. He also served as Chief Medical Officer for Link Medicine and Hypnion, and was Vice President of Neuroscience Development at Wyeth and Pfizer.

At MMS, Dr. Poole provides guidance on the design, conduct, and reporting of global phase 2-4 clinical trials, the implementation of clinical development plans, and global regulatory filings. He has supported a wide range of indications from analgesia, pain, neurology, Alzheimer’s Disease, psychiatry, infectious disease and more.

Dr. Poole earned his undergraduate degree at the University of California, Berkeley and his medical degree from the UC San Diego School of Medicine. He is board certified in internal medicine, having trained at Strong Memorial Hospital at the University of Rochester. He also is board-certified in adult neurology, completing his post-graduate training in neurology at the University of Michigan.

In his free time, he can often be found sailing the waters of Puget Sound, enjoying the incredible scenery.

Learn more about Dr. Poole


“MMS is one of those rare companies that can handle the seemingly impossible, always striving for a better experience for sponsors and outcomes for patients. When I think of the strongest service providers that I know in the pharmaceutical industry, MMS comes to the top every time.”

— Dr. Mike Poole